Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT

Background: Heptocelluar carcinoma (HCC) is insensitive to chemotherapy due to limited bioavailability and acquired drug resistance. Smad3 plays dual roles by inhibiting cell growth initially and promoting the progression of advanced tumors in HCC. However, the role of smad3 in chemosensitivity of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hong-Hao, Chen, Lin, Liang, Hui-Fang, Li, Guang-Zhen, Zhang, Bi-Xiang, Chen, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849060/
https://www.ncbi.nlm.nih.gov/pubmed/27110775
http://dx.doi.org/10.3390/ijms17040610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849060/
https://www.ncbi.nlm.nih.gov/pubmed/27110775
http://dx.doi.org/10.3390/ijms17040610

Ejemplares similares